Antitumor anthracycline glycosides, their preparation, intermedi

Details Antitumor anthracycline glycosides, their preparation, intermedi Antitumor anthracycline glycosides, their preparation, intermedi

1981-10-29

1982-12-28

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Conjugate or complex of monoclonal or polyclonal antibody,...

Conjugated via claimed linking group, bond, chelating agent,...

536 64, 536 53, 536122, A61K 3170, C07H 506, C07H 1524

Patent

active

043661491

ABSTRACT:
Novel antitumor anthracycline glycosides are prepared by condensing daunomycinone with 2,3,4,6-tetradeoxy-3,4-ditrifluoroacetamido-L-lyxo-[or L-arabino-]hexopyranosyl chloride.

REFERENCES:
patent: 4020270 (1977-04-01), Arcamone et al.
patent: 4039663 (1977-08-01), Arcamone et al.
patent: 4067969 (1978-01-01), Penco et al.
patent: 4265885 (1981-05-01), Bargiotti et al.

Affiliated with

Also associated with

Rating

Antitumor anthracycline glycosides, their preparation, intermedi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor anthracycline glycosides, their preparation, intermedi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor anthracycline glycosides, their preparation, intermedi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1336920